Articles / Blog
Reach out to us today! Most Private Insurance Accepted
Former mayor of New York City helped OxyContin manufacturer continue its sales, says report
Posted in Substance Abuse

Rudolph Giuliani, former mayor of New York City, secured an agreement to limit further prosecution of OxyContin manufacturer Purdue Pharma and escape prison term for its executives more than a decade ago, according to a report published in The Guardian. Although Giuliani failed to thwart the criminal conviction over the Purdue’s tactics to downplay the negative side of OxyContin, he managed to strike a deal to help the opioid maker continue with its drug sales. Significantly, painkiller OxyContin is at the center of the ongoing prescription opioid crisis which has claimed more than 200,000 lives between 1999 and 2016.

Purdue Pharma hired Giuliani, currently one of President Donald Trump’s lawyers, to stall a federal investigation into the company’s marketing practices in the mid 2000s. U.S. attorney John Brownlee, who led the investigation, said that he was surprised to note that the Connecticut-based drug major didn’t face stringent action from federal regulators as the company had played a significant role in furthering the opioid crisis. Shortly after his appointment as the U.S. attorney for the western district of Virginia, Brownlee started his investigation in the backdrop of the soaring number of overdose deaths involving prescription opioids in the early 2000s. On examining the circumstances of the killer epidemic, Brownlee discovered that oxycodone, a semi-synthetic opioid sold under brand names such as OxyContin, was the principal cause of overdose deaths.

Purdue now faces a series of lawsuits as several states, including Nevada, Florida, North Carolina, North Dakota, Tennessee and Texas, have joined the growing ranks of complainants against the company. These lawsuits were filed after a federal judge in Cleveland encouraged opioid makers to settle the hundreds of cases filed by local governments alleging unethical prescribing of addictive opioids that resulted in many overdose deaths.

After its launch in 1996, Purdue transformed OxyContin into a multibillion-dollar drug with an aggressive marketing. The company not only told doctors about the effective pain-management benefits of the drug, but also downplayed its addictive nature. It convinced the medical community by overstating the safety of OxyContin. Notably, pain relievers are safe only if a patient adheres to the dosage prescribed by a doctor, strictly for medical purposes. However, non-medical use or abuse could cause addiction, ending in total dependence on the drug.

The need of the hour is to use alternative therapies and non-opioid medications to treat patients grappling with severe pain. It will help fight the ongoing opioid epidemic. Additionally, addiction to oxycodone or any other prescription opioid requires personalized medical interventions at a reputed drug abuse rehabilitation center.

Oxycodone addiction is treatable

Oxycodone is an opioid painkiller that helps patients of chronic pain cope with the condition. Recognized as a Schedule II drug under the Controlled Substances Act (CSA), oxycodone is a habit-forming opioid that may cause severe psychological and physical dependence.

If you know someone suffering from addiction to oxycodone or any other prescription opioid, contact Sovereign Health to seek counseling and treatment. Our evidence-based treatment for oxycodone addiction includes a combination of residential detox and various alternative therapies, followed by counseling sessions. We also impart necessary skills to help patients adapt to a normal life after the completion of the treatment. Call our 24/7 helpline or chat online with our counselor to know more about our world-class oxycodone addiction treatment centers.

Related Posts:

Stay connected with Sovereign Health

Get the latest news on program developments, behavioral health news and company announcements